|
시장보고서
상품코드
2040609
의약품 1차 포장 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 소재별, 지역별 및 부문별 예측(2026-2033년)Primary Pharmaceutical Packaging Market Size, Share & Trends Analysis Report By Product, By Material, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
의약품 1차 포장 시장 개요
세계의 의약품 1차 포장 시장 규모는 2025년에 1,139억 달러로 추계되며, 2026-2033년에 CAGR 6.2%로 성장하며, 1,833억 달러에 달할 것으로 예측됩니다.
세계의 제약 산업의 성장과 선진국과 신흥 국가 모두에서 의약품 소비가 증가함에 따라 의약품 1차 포장에 대한 수요가 크게 증가하고 있습니다.
고령화와 더불어 당뇨병, 심혈관질환, 암 등 만성질환의 유병률 증가로 인해 안전하고 신뢰할 수 있는 약물 투여 시스템의 필요성이 높아지고 있습니다. 또한 바이오의약품 및 전문의약품의 급증으로 제품의 안정성과 무균성을 보장하는 첨단 패키징 솔루션에 대한 수요가 증가하고 있습니다. 특히 인도, 중국 등의 국가에서 제네릭 의약품 제조가 확대되면서 포장에 대한 요구사항이 더욱 높아지고 있습니다. 또한 예방접종 프로그램 및 글로벌 예방접종 구상의 증가로 인해 바이알, 앰플, 프리필드 시린지에 대한 수요가 가속화되고 있습니다. 또한 의약품의 안전성과 포장의 무결성에 대한 환자들의 인식이 높아진 것도 시장 성장에 기여하고 있습니다.
주요 촉진요인으로는 고품질, 무공해 포장 솔루션의 의무화, 의약품 안전에 대한 엄격한 규제 요건을 들 수 있습니다. 바이오의약품 및 주사제 채택이 확대되면서 프리필드 시린지, 무균 바이알과 같은 특수 포장 형태에 대한 수요가 증가하고 있습니다. 수탁제조기관(CMO)과 제약 아웃소싱의 확대도 확장성 있는 포장 솔루션에 대한 수요를 확대시키고 있습니다. 또한 의약품 분야에서 E-Commerce가 부상함에 따라 내구성과 변조 방지 기능을 갖춘 포장의 중요성이 커지고 있습니다. 고배리어성 플라스틱, 유리 대체 소재 등 재료 기술의 발전도 시장 성장을 더욱 촉진하고 있습니다. 유통기한 연장, 습기나 산소 등 환경적 요인으로부터의 보호에 대한 요구도 또 다른 중요한 요인입니다.
각국 정부는 의약품의 안전성, 유효성 및 추적성을 보장하기 위해 엄격한 규제와 가이드라인을 도입하고 있으며, 이는 일차 의약품 포장 표준에 직접적인 영향을 미치고 있습니다. FDA 및 EMA와 같은 규제 당국은 GMP 및 시리얼라이제이션 요건을 철저히 준수하도록 요구하고 있으며, 고품질 포장 솔루션에 대한 수요가 증가하고 있습니다. 신흥 국가에서는 각국 정부가 인센티브와 정책적 틀을 통해 국내 의약품 생산을 지원하고 있으며, 이는 간접적으로 포장 수요를 견인하고 있습니다. 의료에 대한 접근성과 경제성을 높이기 위한 노력으로 의약품 소비가 증가하고 있으며, 이에 따라 포장에 대한 수요도 증가하고 있습니다. 또한 추적 및 추적 시스템 등 위조 방지 대책에 초점을 맞춘 규제와 정책은 첨단 패키징 기술의 채택을 촉진하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 세계의 의약품 1차 포장 시장 : 변수, 동향, 범위
제4장 세계의 의약품 1차 포장 시장 : 제품별 추정·동향 분석
제5장 세계의 의약품 1차 포장 시장 : 소재별 추정·동향 분석
제6장 세계의 의약품 1차 포장 시장 : 지역별 추정·동향 분석
제7장 경쟁 구도
제8장 기업 리스트
KSA 26.06.02Primary Pharmaceutical Packaging Market Summary
The global primary pharmaceutical packaging market size was estimated at USD 113.9 billion in 2025 and is projected to reach USD 183.3 billion, growing at a CAGR of 6.2% from 2026 to 2033. The demand for primary pharmaceutical packaging is rising significantly due to the growth of the global pharmaceutical industry and rising medicine consumption across both developed and emerging economies.
An aging population, coupled with the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer, is driving the need for safe and reliable drug delivery systems. In addition, the surge in biologics and specialty drugs has heightened the demand for advanced packaging solutions that ensure product stability and sterility. The expansion of generic drug manufacturing, particularly in countries like India and China, is further fueling packaging requirements. Moreover, the rise in vaccination programs and global immunization initiatives has accelerated the demand for vials, ampoules, and prefilled syringes. Increasing patient awareness regarding drug safety and packaging integrity is also contributing to market growth.
Key drivers include stringent regulatory requirements for drug safety, which mandate high-quality, contamination-free packaging solutions. The increasing adoption of biologics and injectable drugs is boosting demand for specialized packaging formats such as prefilled syringes and sterile vials. Growth in contract manufacturing organizations (CMOs) and pharmaceutical outsourcing is also expanding the need for scalable packaging solutions. In addition, the rise of e-commerce in pharmaceuticals has increased the importance of durable and tamper-evident packaging. Technological advancements in materials such as high-barrier plastics and glass alternatives are further supporting market growth. The need for extended shelf life and protection from environmental factors like moisture and oxygen is another critical factor.
Governments worldwide are implementing strict regulations and guidelines to ensure drug safety, efficacy, and traceability, which directly impact primary pharmaceutical packaging standards. Regulatory bodies such as the FDA and EMA enforce compliance with Good Manufacturing Practices (GMP) and serialization requirements, boosting demand for high-quality packaging solutions. In emerging economies, governments are supporting domestic pharmaceutical production through incentives and policy frameworks, indirectly driving packaging demand. Initiatives promoting healthcare access and affordability are increasing drug consumption, thereby expanding packaging needs. In addition, regulations focusing on anti-counterfeiting measures, such as track-and-trace systems, are encouraging the adoption of advanced packaging technologies.
Global Primary Pharmaceutical Packaging Market Report Segmentation
This report forecasts revenue growth at a global level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global primary pharmaceutical packaging market report based on product, material, and region:
- Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Bottles
- Blister Packs
- Vials & Ampoules
- Prefilled Syringes & Cartridges
- Caps & Closures
- Others
- Material Outlook (Revenue, USD Billion, 2021 - 2033)
- Plastics & Polymers
- Glass
- Aluminum/Foils
- Rubber/Elastomers
- Others
- Region Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Research Methodology
- 1.1.1. Market Segmentation
- 1.1.2. Market Definition
- 1.2. Research Scope & Assumptions
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- 1.7. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot, 2025 (USD Billion)
- 2.2. Segmental Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Global Primary Pharmaceutical Packaging Market Variables, Trends, and Scope
- 3.1. Market Lineage Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Raw Product Trends
- 3.3. Sustainability Trends
- 3.4. Technology Overview
- 3.5. Regulatory Framework
- 3.6. Market Dynamics
- 3.6.1. Market Driver Analysis
- 3.6.2. Market Restraint Analysis
- 3.6.3. Market Challenge Analysis
- 3.7. Business Environment Analysis
- 3.7.1. Porter's Five Forces Analysis
- 3.7.2. PESTEL Analysis
Chapter 4. Global Primary Pharmaceutical Packaging Market: Product Estimates & Trend Analysis
- 4.1. Key Takeaways
- 4.2. Product Movement Analysis & Market Share, 2025 & 2033
- 4.2.1. Bottles
- 4.2.2. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.2.3. Blister Packs
- 4.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.2.4. Vials & Ampoules
- 4.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.2.5. Prefilled Syringes & Cartridges
- 4.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.2.6. Caps & Closures
- 4.2.6.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 4.2.7. Others
- 4.2.7.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
Chapter 5. Global Primary Pharmaceutical Packaging Market: Material Estimates & Trend Analysis
- 5.1. Key Takeaways
- 5.2. Application Movement Analysis & Market Share, 2025 & 2033
- 5.2.1. Plastics & Polymers
- 5.2.1.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.2.2. Glass
- 5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.2.3. Aluminum/Foils
- 5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.2.4. Rubber/Elastomers
- 5.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.2.5. Others
- 5.2.5.1. Market estimates and forecasts, 2021 - 2033 (USD Billion)
- 5.2.1. Plastics & Polymers
Chapter 6. Global Primary Pharmaceutical Packaging Market: Region Estimates & Trend Analysis
- 6.1. Key Takeaways
- 6.2. Regional Movement Analysis & Market Share, 2025 & 2033
- 6.3. North America
- 6.3.1. North America Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.3.2. U.S.
- 6.3.2.1. U.S. Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.3.3. Canada
- 6.3.3.1. Canada Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.3.4. Mexico
- 6.3.4.1. Mexico Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.4. Europe
- 6.4.1. Europe Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.4.2. Germany
- 6.4.2.1. Germany Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.4.3. UK
- 6.4.3.1. UK Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.4.4. France
- 6.4.4.1. France Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.4.5. Italy
- 6.4.5.1. Italy Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.4.6. Spain
- 6.4.6.1. Spain Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.5. Asia Pacific
- 6.5.1. Asia Pacific Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.5.2. China
- 6.5.2.1. China Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.5.3. India
- 6.5.3.1. India Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.5.4. Japan
- 6.5.4.1. Japan Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.5.5. South Korea
- 6.5.5.1. South Korea Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.5.6. Australia
- 6.5.6.1. Australia Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.6. Latin America
- 6.6.1. Latin America Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.6.2. Brazil
- 6.6.2.1. Brazil Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.6.3. Argentina
- 6.6.3.1. Argentina Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.7. Middle East & Africa
- 6.7.1. Middle East & Africa Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Saudi Arabia Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.7.3. UAE
- 6.7.3.1. UAE Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
- 6.7.4. South Africa
- 6.7.4.1. South Africa Primary Pharmaceutical Packaging Market Estimates & Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. Competitive Landscape
- 7.1. Key Global Players & Recent Developments & Their Impact on the Industry
- 7.2. Vendor Landscape
- 7.2.1. Company Categorization
- 7.2.2. List of Raw Product Suppliers, and Channel Partners
- 7.3. Competitive Dynamics
- 7.3.1. Company Market Position Analysis
- 7.3.2. Company Market Share Analysis
- 7.3.3. Company Heat Map Analysis
- 7.4. Strategy Mapping
- 7.4.1. Expansions
- 7.4.2. Mergers & Acquisitions
- 7.4.3. Collaborations
- 7.4.4. New Product Launches
- 7.4.5. Others
Chapter 8. Company Listing (Overview, Financial Performance, Product Overview)
- 8.1. Amcor plc
- 8.1.1. Company Overview
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.2. Gerresheimer AG
- 8.3. SCHOTT AG
- 8.4. West Pharmaceutical Services, Inc.
- 8.5. AptarGroup, Inc.
- 8.6. Becton, Dickinson and Company
- 8.7. Berry Global
- 8.8. CCL Industries
- 8.9. SGD Pharma
- 8.10. Nipro Corporation
